PureTech Health plc
PRTCY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.23B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.23 Billion |
|---|---|
| Enterprise Value | $4.13 Billion |
| Earnings per Share | $- |
| Beta | 0.79 |
| Outstanding Shares | - |
Return
| Return on Equity | 13.50% |
|---|---|
| Return on Assets | 8.18% |
| Return on Invested Capital | -8.54% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 338.81 |
| Enterprise Value to EBIT | -83.09 |
| Enterprise Value to Net Income | 79 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 22, 2026
EPS Estimate
$-1.16
Consensus analyst estimateRevenue Estimate
$24.80 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 29, 2027
EPS Estimate
$-1.14
Consensus analyst estimateRevenue Estimate
$5.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PureTech Health Plc
66 employees
CEO: Daphne Zohar
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurologic...